ACUITY® Pro 8101Recalls & reported problems
Boston Scientific Corporation · Guide Catheter · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 08714729932468), received between Feb 7, 2019 and Mar 13, 2023 — classified as 1 injury, 4 malfunctions.
The most frequently reported specific device problem is “Material Integrity Problem” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Material Integrity Problem2
- Difficult to Insert1
Patient problems
- No Consequences Or Impact To Patient2
- No Known Impact Or Consequence To Patient2
- Vascular Dissection1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryMar 13, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING THE PROCEDURE, A DISSECTION OCCURRED IN THE LEFT VENTRICLE. AN EXTENDED HOOK CATHETER (8104) WAS USED TO ACCESS THE CORONARY SINUS (CS), AND THE LEFT VENTRICULAR (LV) LEAD WAS ADVANCED ALONG THE CS USING THE 8104 MODEL. THIS ACUITY PRO CATHETER (8101) WAS CHOSEN TO ADVANCE THE LV LEAD ACROSS A TIGHT TURN IN THE CS. THIS WAS NOT SUCCESSFUL AT FIRST, THEREFORE, CONTRAST WAS INJECTED THROUGH THE 8101 CATHETER TO ASSESS, AND THE DISSECTION WAS CLEARLY VISIBLE ON FLUOROSCOPY. THE PHYSICIAN SUSPECTED THAT THIS CATHETER WAS AT FAULT, CAUSING THE DISSECTION WHEN THE CONTRAST WAS INJECTED AGAINST THE WALL OF THE VESSEL. HOWEVER, IT COULD HAVE BEEN DUE TO THE ATTEMPT TO ADVANCE THE LV LEAD ACROSS THE NARROW VESSEL. THE 8101 MODEL CONTINUED TO BE USED TO ACCESS ANOTHER VESSEL BELOW THE POINT OF DISSECTION, BEFORE BEING EXCHANGED FOR AN 8103 MODEL, WHICH SUCCESSFULLY ENTERED THE CHOSEN VESSEL BRANCH, AND THE LV LEAD WAS SUCCESSFULLY IMPLANTED. THE CRT-D, RIGHT ATRIAL LEAD, AND THE RIGHT VENTRICULAR LEAD WERE ALSO SUCCESSFULLY IMPLANTED. A POST IMPLANT ECHOCARDIOGRAM WAS PERFORMED TO CONFIRM THAT THERE WAS NO SERIOUS FLUID BUILDUP AROUND THE HEART DUE TO THE DISSECTI
Patient problems: Vascular Dissection
MAUDE report 16534747 ↗MalfunctionNov 2, 2020Material Integrity Problem; Material Integrity Problem
IT WAS REPORTED THAT THIS CATHETER TORE APART DURING A PROCEDURE TWO CENTIMETER DISTAL TO HUB AND TORE PERPENDICULAR TO CATHETER LENGTH AND CROSS CUT. THE PHYSICIAN HAD NOT STARTED WITH THE CUTTER YET DURING THIS INCIDENT. THE CATHETER WAS NEVER IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10775694 ↗MalfunctionAug 7, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS PRODUCT WAS RETURNED WITH NO REPORTED PRODUCT PERFORMANCE ISSUES AND NO REPORTED ADVERSE PATIENT EFFECTS. INITIAL ANALYSIS COMPLETED IN OUR POST MARKET QUALITY ASSURANCE LABORATORY IDENTIFIED A PRODUCT PERFORMANCE ISSUE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8872348 ↗MalfunctionApr 26, 2019Difficult to Insert; Difficult to Insert
IT WAS REPORTED THAT DURING AN IMPLANT PROCEDURE ON (B)(6) 2019 A GUIDING CATHETER WAS ATTEMPTED TO BE USED TO INSERT THE LEFT VENTRICLE LEAD BUT THE PART AROUND THE TIP GOT LIFTED AT THE BIFURCATION. IT WAS DETERMINED DUE TO SAFETY PRECAUTIONS TO DISCONTINUE USE. THE LEFT VENTRICLE LEAD WAS INSERTED SUCCESSFULLY WITHOUT THE USE OF A CATHETER. NO ADVERSE HEALTH OUTCOMES WERE REPORTED. THIS CATHETER WILL NOT BE RETURNED AS INDICATED DURING THE INITIAL REPORT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8558226 ↗MalfunctionFeb 7, 2019Material Integrity Problem; Material Integrity Problem
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT WHEN SLITTING CATHETER ABOUT TWO INCHES FROM THE DISTAL END, THE CATHETER BROKE AND HAD TO BE SNIPPED WITH SCISSORS AND HEMASTAT. THE CATHETER BROKE INTO MANY PIECES AND WAS NOT RETURNED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8314578 ↗
Other CATHETER, PERCUTANEOUS devices
- WATCHMAN FXD Curve™ Access System M635TU80020Boston Scientific Corporation · Catheter, percutaneous1 recall47 deaths654 reports
- NA C315HIS02Medtronic, Inc. · Catheter, percutaneous1 recall369 reports
- WATCHMAN TruSteer™ Access System M635TU90050Boston Scientific Corporation · Catheter, percutaneous1 recall28 deaths302 reports
- Guidezilla™ II H7493933515060Boston Scientific Corporation · CATHETER, PERCUTANEOUS1 recall3 deaths278 reports
- Velocity Delivery Microcatheter VEL160STR-APenumbra, Inc. · CATHETER, PERCUTANEOUS297 reports
- Guidezilla™ H7493924215050Boston Scientific Corporation · CATHETER, PERCUTANEOUS294 reports
- WATCHMAN™ TruSeal™ Access System M635TU70020Boston Scientific Corporation · Catheter, percutaneous1 recall11 deaths217 reports
- Lantern Delivery Catheter PXSLIMLAN135T45Penumbra, Inc. · CATHETER, PERCUTANEOUS220 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page